Work Here?
Industries
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$64.9M
Headquarters
Waltham, Massachusetts
Founded
2019
Linus Health provides tools for the early detection of Alzheimer's and other forms of dementia by enhancing cognitive assessments with artificial intelligence. Their main product is a digital cognitive assessment platform that combines traditional tests with AI-driven analysis, allowing for efficient and scientifically validated early detection. A key feature is DCTclock, an AI-enhanced version of the traditional clock drawing test, developed through research at MIT and Lahey. The company's goal is to improve patient outcomes by enabling timely and accurate cognitive assessments in a growing market for dementia care.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$64.9M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Health, dental, vision & life insurance
Unlimited PTO
Parental leave
401K with 6% match
Performance Bonus
Employee Stock Purchase Plan
Work From Home Policy
Employee Referral Incentive program
Company Social Outings
- Linus Health has introduced Anywhere for Health Systems(TM), an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia.
Linus Health Launches AI-Powered Remote Assessment to Combat Undetected Cognitive Impairment. by Jasmine Pennic 03/21/2025 Leave a Comment. What You Should Know: â Linus Health has introduced Anywhere for Health Systemsâ˘, an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia. â The new solution empowers health systems to conduct accurate and efficient cognitive evaluations remotely, significantly improving early detection rates and streamlining patient care.Delivering Clinical-Grade Cognitive Assessments RemotelyThe alarming statistic that 92% of MCI cases go undetected highlights a major gap in current healthcare practices. Traditional MCI detection methods, involving in-person screenings and lengthy neuropsychological evaluations, are often time-consuming and resource-intensive, placing a strain on already overburdened clinicians.Anywhere for Health Systems⢠offers a solution by providing a convenient and rapid assessment that patients or their care partners can administer from home via laptop, tablet, or phone, at the request of their primary care provider (PCP). This FDA Class II medical device utilizes a peer-reviewed battery of tests to assess four critical cognitive domains.Anywhere for Health Systems⢠complements Linus Healthâs broader suite of cognitive health solutions, including Radar and a portfolio of digital cognitive assessments and personalized action plans. Linus Health collaborates with health systems to tailor workflows and optimize patient and provider experiences.âThis self-administered test is the solution healthcare systems have been looking for,â said John Showalter, MD, MSIS, chief strategy and product officer at Linus Health
Neurogen Biomarking announces collaboration with Linus Health bringing easy access to cutting-edge technology to support early detection of Mild Cognitive Impairment and dementia due to Alzheimer's disease.
Brook Health, a leader in remote patient care and AI-powered health support, has officially announced a partnership with Linus Health, a digital health company enabling early detection of Alzheimer's and other dementias, to conceive a simplistic brand of cognitive care.
As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this yearâs event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! Iâm looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this yearâbut with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. Iâm also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nationâs first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, Iâm expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, Iâm also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year
$125k - $150k/yr
Remote in USA
$125k - $150k/yr
Remote in USA
Find jobs on Simplify and start your career today
Discover companies similar to Linus Health
Industries
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$64.9M
Headquarters
Waltham, Massachusetts
Founded
2019
Remote in USA
$125k - $150k/yr
Remote in USA
$125k - $150k/yr
Remote in USA
Find jobs on Simplify and start your career today
Discover companies similar to Linus Health